ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors

Clinical trial NCT01154426 · COMPLETED

Trial details

NCT number: NCT01154426
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Adult Solid Neoplasm BRCA1 Mutation Carrier BRCA2 Mutation Carrier

Start date: 2010-05-01
Primary completion: 2013-10-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.